ANI Pharmaceuticals, Inc. (ANIP)

80.17 +0.23 (+0.29%) USD  |  NASDAQ  |  Apr 22, 13:51
More

ANI Pharmaceuticals Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for ANIP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Liquidia Corp. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Indivior Pharmaceuticals, Inc. Upgrade
Replimune Group, Inc. Upgrade
ADMA Biologics, Inc. Upgrade